ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

ClinicalTrials.gov ID: NCT06074562

Public ClinicalTrials.gov record NCT06074562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Study identification

NCT ID
NCT06074562
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
405 participants

Conditions and interventions

Interventions

  • LY3556050 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2023
Primary completion
Jun 10, 2025
Completion
Jun 10, 2025
Last update posted
Jul 2, 2025

2023 – 2025

United States locations

U.S. sites
34
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa Chandler Arizona 85225
Headlands Research - Scottsdale Scottsdale Arizona 85260
Orange Grove Family Practice Tucson Arizona 85741
Preferred Research Partners Little Rock Arkansas 72211
Hope Clinical Research, Inc. Canoga Park California 91303
Valley Clinical Trials, Inc. Northridge California 91325
Northern California Research - Sacramento Sacramento California 95821
CMR of Greater New Haven, LLC Hamden Connecticut 06517
Suncoast Research Group Miami Florida 33135
New Horizon Research Center Miami Florida 33165
Northwestern University Chicago Illinois 60611
Alliance for Multispecialty Research, LLC Wichita Kansas 67205
Alliance for Multispecialty Research, LLC Lexington Kentucky 40509
Care Access - Lake Charles Lake Charles Louisiana 70601
MedVadis Research Corporation Waltham Massachusetts 02451
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157
StudyMetrix Research City of Saint Peters Missouri 63303
Alliance for Multispecialty Research, LLC Kansas City Missouri 64114
Clinvest Research LLC Springfield Missouri 65807
Las Vegas Medical Research Las Vegas Nevada 89128
UniMed Center East Brunswick New Jersey 08816
North Suffolk Neurology Port Jefferson Station New York 11776
Lucas Research - Hickory Hickory North Carolina 28601
Lucas Research, Inc Morehead City North Carolina 28557
Velocity Clinical Research, Medford Medford Oregon 97504
Tristar Clinical Investigations Philadelphia Pennsylvania 19114
Suburban Research Associates West Chester Pennsylvania 19380
New Phase Research and Development Knoxville Tennessee 37909
FutureSearch Trials of Neurology Austin Texas 78731
Juno Research Houston Texas 77040
Consano Clinical Research, LLC Shavano Park Texas 78231
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Northwest Clinical Research Center Bellevue Washington 98007
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06074562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06074562 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →